Vaccination News Home Page

http://www.nature.com/nsu/021216/021216-8.html

nature science update
updated at midnight GMT today is monday, december 23
features
nature science update home
content
news
features
by subject
conferences
services
send to a friend
printable version
ealert
search
help
feedback
information
about the site
about us
amersham logo
American Society for Cell Biology,
San Francisco, December, 2002

 

Soap slays sleeping sickness

Bacterial hangover renders parasite susceptible to triclosan.
18 December 2002

HELEN PEARSON

 

Triclosan is common in western cleaning products.
© alamy.com

 

The widespread killer sleeping sickness might be treated with the cheap antibiotic triclosan, scientists revealed at the American Society for Cell Biology meeting in San Francisco, California, this week.

Transmitted by the tsetse fly, the disease affects up to half-a-million people in rural sub-Saharan Africa. Kimberly Paul of Johns Hopkins School of Medicine in Baltimore, Maryland, and her team found that the causative parasite, Trypanosoma brucei, stops growing in a tube infused with triclosan.

The antibiotic is common in today's Western cleaning products: "You can't find a hand soap without it," says Paul. It could be an improvement on existing drugs such as arsenic derivatives, which are also toxic to patients.

The new finding is surprising because triclosan is an antibacterial chemical - but T. brucei is not a bacteria. It appears to have remnants of bacterial genes that render it vulnerable to the drug, Paul found.

"It is both an exciting and anticipated development," says Namita Surolia of Jawaharlal Nehru Centre for Advanced Scientific Research in Bangalore, India. She and her colleagues showed that the mosquito-borne malaria parasite Plasmodium falciparum is also attacked by triclosan1.

Paul's team found that certain genes that T. brucei uses to build molecules called fatty acids are more closely related to equivalent genes in bacteria than those in mammals or yeast. The researchers used DNA sequence data from the T. brucei genome project.

This means that an antibacterial drug will attack the parasite but not human cells. "That's what I find very exciting," says Paul. "There's a pharmacopoeia of drugs designed for other bacterial infections - maybe we could piggy-back off those."

Researchers have yet to test whether the drug actually alleviates the symptoms of sleeping sickness or malaria. They might also be foiled if the wily parasites develop resistance to triclosan.

References
  1. Surolia, N. & Surolia, A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nature Medicine, 7, 167 - 73, (2001). |Homepage|

© Nature News Service / Macmillan Magazines Ltd 2002
related stories
Groceries trip triclosan switch
25 May 2001
The trials of triclosan
1 April 1999
resources
Malaria Special
links out
American Society for Cell Biology
WHO sleeping sickness
more news
Green snow washes clean away
23 December 2002
Electric dreams infect waking memories
23 December 2002
Black Crunch jams Universal cycle
23 Decemeber 2002
Chemical attraction solves geometric puzzles
23 December 2002
Foot-and-Mouth would have jumped fence
23 December 2002
Ultrasound scan spots Down's syndrome
20 December 2002
Humans more similar than different
20 December 2002

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.